Toggle navigation
Drugs
Combinations
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Antithrombotic Agents
Indications and Reactions:
Role
Indications
Reactions
Secondary
Drug Use For Unknown Indication
18.5%
Antiplatelet Therapy
16.3%
Atrial Fibrillation
13.3%
Cerebrovascular Accident Prophylaxis
11.9%
Acute Coronary Syndrome
10.4%
Anticoagulant Therapy
8.1%
Hypertension
5.2%
Thrombosis Prophylaxis
3.7%
Percutaneous Coronary Intervention
3.0%
Iga Nephropathy
1.5%
Type 2 Diabetes Mellitus
1.5%
Acute Myocardial Infarction
0.7%
Hepatic Neoplasm Malignant
0.7%
Ischaemic Stroke Nos
0.7%
Lung Disorder
0.7%
Multiple Sclerosis
0.7%
Pain
0.7%
Product Used For Unknown Indication
0.7%
Prophylaxis Against Gastrointestinal Ulcer
0.7%
Renal Cell Carcinoma
0.7%
Atrial Fibrillation
19.0%
Embolic Stroke
9.5%
Haemorrhage
9.5%
Pulmonary Embolism
7.1%
Death
4.8%
Haemorrhage Intracranial
4.8%
Haemorrhoidal Haemorrhage
4.8%
International Normalised Ratio Fluctuation
4.8%
Joint Arthroplasty
4.8%
Pneumonia
4.8%
Renal Failure
4.8%
Cerebrovascular Accident
2.4%
Coronary Arterial Stent Insertion
2.4%
Drug Ineffective
2.4%
Epistaxis
2.4%
Gastrointestinal Haemorrhage
2.4%
Haemoptysis
2.4%
Injection Site Haemorrhage
2.4%
International Normalised Ratio Increased
2.4%
Menorrhagia
2.4%
Concomitant
Multiple Myeloma
15.7%
Hypertension
10.1%
Product Used For Unknown Indication
10.0%
Thrombosis Prophylaxis
8.6%
Type 2 Diabetes Mellitus
7.5%
Prophylaxis
5.1%
Colon Cancer
4.6%
Diabetes Mellitus
4.3%
Blood Pressure Abnormal
3.5%
Atrial Fibrillation
3.4%
Cardiac Disorder
3.1%
Smoking Cessation Therapy
3.1%
Nuclear Magnetic Resonance Imaging
3.0%
Imaging Procedure
2.9%
Prostate Cancer
2.9%
Bone Pain
2.7%
Infection Prophylaxis
2.7%
Infection
2.4%
Pulmonary Arterial Hypertension
2.4%
Angiogram
2.2%
Renal Failure Acute
12.6%
Renal Failure
8.1%
Thrombocytopenia
7.2%
Dyspnoea
6.3%
Cardiac Failure Congestive
5.4%
Death
5.4%
Depression
4.5%
International Normalised Ratio Increased
4.5%
Myocardial Infarction
4.5%
Nausea
4.5%
Weight Decreased
4.5%
Cerebral Haemorrhage
3.6%
Cerebral Infarction
3.6%
General Physical Health Deterioration
3.6%
Hepatitis
3.6%
Melaena
3.6%
Neutropenia
3.6%
Pain In Extremity
3.6%
Palpitations
3.6%
Pulmonary Embolism
3.6%
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Drug Data
Drugs
Combinations